Upload others
View 1
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
17th International Haemovigilance Seminar 9-11 …ihs-seminar.org/content/uploads/Abiyi-Belay-Ambaye-Ethiopia.pdf · 17th International Haemovigilance Seminar 9-11 March,Paris - France
Blood & Biologicals Section 2
NOVUS BIOLOGICALS ANTIBODIES FOR NEUROSCIENCE
A guide to establishing a national haemovigilance systemapps.who.int/iris/bitstream/10665/250233/1/9789241549844-eng.pdf · A guide to establishing a national haemovigilance ... A
Quality Assurance for blood products and related biologicals · Quality Assurance for blood products and related biologicals Dr Ana Padilla . Blood Products & related Biologicals
Introduction to Biosimilars Biologicals Marketing Authorization Directorate Central Administration for Pharmaceutical Affairs [email protected]
Serious Hazards of Transfusion (SHOT) haemovigilance · PDF fileSerious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety Paula H. B. Bolton-Maggs1
Overview of international haemovigilance 合肥/Overvi… · International Haemovigilance Network Australia New Zealand Singapore S. Korea Japan India Pakistan Iran Namibia South
Consultation: Guidance on variations to biologicals ... · Web viewConsultation: Guidance on variations to biologicals ... (Guidance on variations to biologicals included in the
Haemovigilance report 2009 - ansm.sante.fr · Haemovigilance report 2009 5/82 French Agency for the safety of health products FOREWORD Article L1221-13, modified by order n°2005-1087
PAS-E PLATELET ADDITIVE SOLUTION HAEMOVIGILANCE REPORT ... · PAS-E PLATELET ADDITIVE SOLUTION HAEMOVIGILANCE REPORT, RESIDUAL RISK AND RISK/BENEFIT UPDATE Chryslain Sumian, Frank
Australian Haemovigilance Report - blood...6 AUSTRALIAN HAEMOVIGILANCE REPORT DATA FOR 2011–12 AND 2012–13 MESSAGE FROM THE GENERAL MANAGER OF THE NATIONAL BLOOD AUTHORITY On behalf
Biologicals’ HPV TM (HPV): GSK Biologicals’...Study Number: 115887 (HPV -073) Title: Safety and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ HPV-16/18 L1 VLP AS04 vaccine
Consultation: Guidance on variations to biologicals ... Web viewConsultation: Guidance on variations to biologicals ... (Guidance on variations to biologicals included in the ... standard
Presentation - Quality of biologicals of biologicals. K. Ho. ... • Fermentation/culture process • Purification process ... Presentation - Quality of biologicals Author:
Quality of biologicals recombinant DNA
International Association for Biologicals - NIHS · International Association for Biologicals Presentation to Japanese Biologicals Forum by Tony Lubiniecki Tokyo, 16January2008
Prevention of TACO – what Haemovigilance data tell us
Blood Transfusion Reactions Haemovigilance Serious Hazards of Transfusion ( SHOT )
Biologicals and Biosimilars Borut
Haemovigilance by JRCS - jrc.or.jp · Haemovigilance by JRCS 2007 Furthermore, 6-month inventory hold of plasma used in manufacturing plasma derivatives was started in 2001, and 6-month
Shipping Biologicals Training - BU
Australian regulatory guidelines for biologicals
BIOLOGICALS VS BIOSIMILARS
Blood ready for issue National Haemovigilance Programme...Annual Report 2005 Blood ready for issue National Haemovigilance Programme Haemovigilance NNZBAD1020 Hae '06 AR Cov 2.indd
nib.gov.innib.gov.in/Haemovigilance/haemovigilance_newsletter_new.pdf · 2018-03-10 · held on 29th Nov, 2012 Highlights of 1st Meeting of Haemovigilance Core Group held on 7th Jan,2013
Global Consultation on Haemovigilance · The WHO Global Consultation on Haemovigilance was held in Dubai, United Arab Emirates on 20-22 November 2012 and was jointly organized by
Catalogo NBS Biologicals
FUNGICIDES, BACTERICIDES, AND BIOLOGICALS FOR …
Haemovigilance Annual report 2014 - Swissmedic · Haemovigilance Annual report 2014 The annual report was written by: Dr. Lorenz Amsler and Dr. Markus Jutzi ... BPr blood product
